BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16559085)

  • 1. Mode of action of nitrofurazone.
    McCalla DR; Reuvers A; Kaiser C
    J Bacteriol; 1970 Dec; 104(3):1126-34. PubMed ID: 16559085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of nitrofurazone resistance in Escherichia coli.
    McCalla DR; Kaiser C; Green MH
    J Bacteriol; 1978 Jan; 133(1):10-6. PubMed ID: 338576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study on 1-nitropyrene and nitrofurazone reductases in Escherichia coli.
    Narai N; Kitamura S; Tatsumi K
    J Pharmacobiodyn; 1984 Jun; 7(6):407-13. PubMed ID: 6384469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RESISTANCE AND CROSS RESISTANCE OF ESCHERICHIA COLI S MUTANTS TO THE RADIOMIMETIC AGENT NITROFURAZONE.
    WOODY-KARRER P; GREENBERG J
    J Bacteriol; 1963 Jun; 85(6):1208-16. PubMed ID: 14047210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations to nitrofurantoin and nitrofurazone resistance in Escherichia coli K12.
    Breeze AS; Obaseiki-Ebor EE
    J Gen Microbiol; 1983 Jan; 129(1):99-103. PubMed ID: 6339681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrofurazone-reducing enzymes in E. coli and their role in drug activation in vivo.
    McCalla DR; Olive P; Tu Y; Fan ML
    Can J Microbiol; 1975 Oct; 21(10):1484-91. PubMed ID: 136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen-sensitive and -insensitive nitroreduction by Escherichia coli and rat hepatic microsomes.
    Peterson FJ; Mason RP; Hovsepian J; Holtzman JL
    J Biol Chem; 1979 May; 254(10):4009-14. PubMed ID: 374406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and excision of nitrofuran-DNA adducts in Escherichia coli.
    Wentzell B; McCalla DR
    Chem Biol Interact; 1980 Aug; 31(2):133-50. PubMed ID: 6993026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone. Reversed binding orientations in different redox states of the enzyme.
    Race PR; Lovering AL; Green RM; Ossor A; White SA; Searle PF; Wrighton CJ; Hyde EI
    J Biol Chem; 2005 Apr; 280(14):13256-64. PubMed ID: 15684426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nitrofurazone on bacterial RNA and ribosome synthesis and on the function of ribosomes.
    Tu Y; McCalla DR
    Chem Biol Interact; 1976 Jul; 14(1-2):81-91. PubMed ID: 782735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on oxygen-insensitive nitrofuran reductase in Escherichia coli B/r.
    Tatsumi K; Doi T; Koga N; Yoshimura H; Koga H; Horiuchi T
    J Biochem; 1981 Mar; 89(3):855-9. PubMed ID: 7026544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Nitrofurazone (CAS No. 59-87-0) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1988 Jun; 337():1-183. PubMed ID: 12732899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
    Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique structural features in DNA polymerase IV enable efficient bypass of the N2 adduct induced by the nitrofurazone antibiotic.
    Kottur J; Sharma A; Gore KR; Narayanan N; Samanta B; Pradeepkumar PI; Nair DT
    Structure; 2015 Jan; 23(1):56-67. PubMed ID: 25497730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FURTHER STUDIES OF ULTRAVIOLET-SENSITIVE MUTANTS OF ESCHERICHIA COLI STRAIN B.
    HILL RF; FEINER RR
    J Gen Microbiol; 1964 Apr; 35():105-14. PubMed ID: 14171254
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of available antimicrobial coated Foley catheters against Escherichia coli, including strains resistant to extended spectrum cephalosporins.
    Johnson JR; Johnston BD; Kuskowski MA; Pitout J
    J Urol; 2010 Dec; 184(6):2572-7. PubMed ID: 21030047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1992 Jun; 29(6):661-8. PubMed ID: 1506349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [POLYMYXIN M AND NITROFURAN PREPARATIONS AS NEW DRUGS FOR THE SPECIFIC TREATMENT OF COLIENTERITIS].
    CHERNOMORDIK AB
    Pediatriia; 1964 Aug; 43():72-3. PubMed ID: 14249600
    [No Abstract]   [Full Text] [Related]  

  • 19. Type I nitroreductases of Escherichia coli.
    Bryant DW; McCalla DR; Leeksma M; Laneuville P
    Can J Microbiol; 1981 Jan; 27(1):81-6. PubMed ID: 7011517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferable nitrofuran resistance conferred by R-plasmids in clinical isolates of Escherichia coli.
    Breeze AS; Obaseiki-Ebor EE
    J Antimicrob Chemother; 1983 Nov; 12(5):459-67. PubMed ID: 6368515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.